| Literature DB >> 30020334 |
Evelyn Carla Borsari Mauricio1, Maria Carolina Barbosa Teixeira Lopes2, Ruth Ester Assayag Batista3, Meiry Fernanda Pinto Okuno4, Cássia Regina Vancini Campanharo4.
Abstract
OBJECTIVES: to identify the care measures performed after cardiorespiratory arrest (CRA) and to relate them to the neurological status and survival at four moments: within the first 24 hours, at the discharge, six months after discharge, and one year after discharge.Entities:
Mesh:
Year: 2018 PMID: 30020334 PMCID: PMC6053291 DOI: 10.1590/1518-8345.2308.2993
Source DB: PubMed Journal: Rev Lat Am Enfermagem ISSN: 0104-1169
Demographic and clinical characteristics of study patients. São Paulo, SP, Brazil, 2016 (N = 88)
| Characteristics | n(%) | |
| Age | ||
| Mean ± SD* | 66.2 ± 16.5 | |
| Median (minimum-maximum) | 68.0 (17-9) | |
| Sex | ||
| Male | 52 (59.1) | |
| Female | 36 (40.1) | |
| Skin color | ||
| White | 53 (60.2) | |
| Brown | 19 (21.6) | |
| Black | 12 (13.6) | |
| Yellow | 4 (4.5) | |
| Presence of comorbidities | ||
| Yes | 82 (93.2) | |
| No | 6 (6.8) | |
| Previous CRA† | ||
| Yes | 2 (2.3) | |
| No | 86 (97.7) | |
| CPC‡ pre-CRA† | ||
| 1 | 23 (26.1) | |
| 2 | 46 (52.3) | |
| 3 | 18 (20.4) | |
| 4 and 5 | 1 (1.1) | |
| Conscious at admission | ||
| Yes | 63 (71.6) | |
| No | 25 (28.4) | |
| Breathing at admission | ||
| Yes | 68 (77.3) | |
| No | 20 (22.7) | |
| Pulse at admission | ||
| Yes | 72 (81.8) | |
| No | 16 (18.2) | |
*SD: standard deviation; †CRA: cardiorespiratory arrest; ‡CPC: Glasgow-Pittsburgh Cerebral Performance Categories
Characteristics of cardiorespiratory arrest events and interventions performed during the care of the study patients. São Paulo, SP, Brazil, 2016 (N = 88)
| Characteristics | n (%) | |
| Place | ||
| Intra-hospital | 76 (86.3) | |
| Extra-hospital | 12 (13.6) | |
| Witnessed | ||
| Yes | 87 (98.8) | |
| No | 1 (1.1) | |
| Immediate cause | ||
| Respiratory failure | 28 (31.8) | |
| Hypotension | 19 (21.6) | |
| Metabolic change | 18 (20.4) | |
| Ischemia or myocardial infarction | 15 (17.0) | |
| Lethal arrhythmia | 5 (5.6) | |
| Unknown | 3 (3.3) | |
| Initial rhythm | ||
| Pulseless electrical activity | 50 (58.1) | |
| Asystolia | 9 (10.2) | |
| Ventricular fibrillation | 8 (9.1) | |
| Ventricular tachycardia | 2 (2.2) | |
| Unknown | 9 (10.2) | |
| Performed interventions | ||
| Thoracic ventilations and compressions | 88 (100.0) | |
| Defibrillation | ||
| No | 71 (80.6) | |
| Yes | 17 (19.3) | |
| Advanced airway access | ||
| Yes | 68 (77.2) | |
| No | 20 (22.7) | |
| Epinephrine | ||
| Yes | 83 (94.3) | |
| No | 5 (5.6) | |
Post-cardiorespiratory care after the first 24 hours in the study patients. São Paulo, SP, Brazil, 2016 (N = 80)
| Care measures | n (%) |
| Advanced airway access | 77(96.2) |
| Indwelling bladder catheterization | 60(68.1) |
| Systolic blood pressure ≥ 90 mmHg | 52(59.0) |
| Investigation of the cause of cardiorespiratory arrest | 51(57.9) |
| Vasoactive drugs | 51(57.9) |
| Mean blood pressure ≥ 65 mmHg | 50(56.8) |
| Prevention of hyperthermia | 43(48.8) |
| 12-lead electrocardiogram | 42(47.7) |
| Central venous access | 40(45.4) |
| Crystalloid solutions | 38(43.1) |
| Continuous sedation | 38(43.1) |
| Chest X-ray | 31 (35.2) |
| Transfer to intensive care unit | 24(27.2) |
| Oxygen saturation from 94 to 98% | 24(27.2) |
| Arterial blood gas analysis every 6 hours | 17(19.3) |
| Urine output between 0.5 and 1 ml/kg/h | 16(18.1) |
| Monitoring of oxygen saturation | 15(17.0) |
| Monitoring of noninvasive blood pressure | 15(17.0) |
| Antiarrhythmic drugs | 14(15.9) |
| Laboratory tests every 6 hours | 14(15.9) |
| Monitoring of respiratory rate | 13(14.7) |
| Monitoring of temperature | 12(13.6) |
| Capillary glycemia 144 to 180 mg/dl | 10(11.3) |
| Electrocardiogram monitoring | 9(10.2) |
| Hemodynamic | 9(10.2) |
| Monitoring of urine output | 7(7.9) |
| Enteral nutrition | 7(7.9) |
| Monitoring of capillary glycemia | 5(5.6) |
| Respiratory rate of 10 to 12 rpm | 4(4.5) |
| Anticonvulsants | 4(4.5) |
| Echocardiogram | 3(3.4) |
| Monitoring of noninvasive blood pressure | 3(3.4) |
| CO2* partial pressure between 40 and 45 mmHg | 2(2.2) |
| Central venous pressure from 8 to 12 cmH2O | 2(2.2) |
| Monitoring of central venous pressure | 1(1.1) |
*CO2: carbon dioxide
Association of post-cardiorespiratory arrest care with survival of the studied patients in the first 24 hours, six months after discharge, and one year after discharge. São Paulo, SP, Brazil, 2016
| p | |
| Monitoring of respiratory rate | 0.01 |
| Monitoring of oxygen saturation | 0.01 |
| Oxygen saturation from 94 to 98% | 0.01 |
| Monitoring of noninvasive blood pressure | 0.01 |
| Systolic blood pressure ≥ 90 mmHg | 0.01 |
| Monitoring of invasive blood pressure | 0.03 |
| Mean blood pressure ≥ 65 mmHg | 0.01 |
| 12-lead electrocardiogram | 0.01 |
| Monitoring of temperature | 0.01 |
| Prevention of hyperthermia | 0.03 |
| Chest X-ray | 0.01 |
| Indwelling bladder catheterization | 0.01 |
| Urine output between 0.5 and 1 ml/kg/h | 0.04 |
| Continuous sedation | 0.01 |
| Transfer to intensive care unit | 0.01 |
| 6-month survival (n = 10) | p |
| Oxygen saturation from 94 to 98% | 0.02 |
| Vasoactive drugs | 0.03 |
| Transfer to intensive care unit | 0.03 |
| One-year survival (n = 9) | p |
| Monitoring of respiratory rate | 0.01 |
| Monitoring of oxygen saturation | 0.01 |
| Oxygen saturation from 94 to 98% | 0.01 |
| Monitoring of noninvasive blood pressure | 0.01 |
| Vasoactive drugs | 0.04 |
| Antiarrhythmic drugs | 0.02 |
| Electrocardiogram monitoring | 0.01 |
| 12-lead electrocardiogram | 0.02 |
| Hemodynamic | 0.01 |
*Pearson’s Chi-square test (p < 0.005)